User profiles for David Hillus
David HillusDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin … Verified email at charite.de Cited by 1730 |
[HTML][HTML] mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
The Omicron variant of SARS-CoV-2 is causing a rapid increase in infections across the
globe. This new variant of concern carries an unusually high number of mutations in key …
globe. This new variant of concern carries an unusually high number of mutations in key …
Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021
…, R Helbok, ME Hellemons, D Hillus… - Jama, 2022 - jamanetwork.com
Importance Some individuals experience persistent symptoms after initial symptomatic
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …
SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of …
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …
D Hillus, T Schwarz, P Tober-Lau… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19
…, I Wirsching, C Wollboldt, Y Wu, G Schwanitz, D Hillus… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …
to severe organ damage and death. We characterized the time-dependent progression of …
[HTML][HTML] A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
…, R Helbok, ME Hellemons, D Hillus… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Objective: To estimate by country and territory of the number of patients affected by long
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …
COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery …
[HTML][HTML] Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
…, T Schwarz, K Vanshylla, D Hillus… - The Lancet …, 2021 - thelancet.com
Health-care workers were enrolled at Charité-Universitätsmedizin Berlin (n= 107) and older
people were enrolled at an assisted living facility in Berlin, Germany (n= 82).(A) Anti-S1 IgG …
people were enrolled at an assisted living facility in Berlin, Germany (n= 82).(A) Anti-S1 IgG …
[PDF][PDF] Complement activation induces excessive T cell cytotoxicity in severe COVID-19
…, M Barone, P Tober-Lau, ET Helbig, D Hillus… - Cell, 2022 - cell.com
Severe COVID-19 is linked to both dysfunctional immune response and unrestrained
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …
[HTML][HTML] Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany
T Schwarz, P Tober-Lau, D Hillus… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…
[HTML][HTML] Immunogenicity of COVID-19 tozinameran vaccination in patients on chronic dialysis
E Schrezenmeier, L Bergfeld, D Hillus… - Frontiers in …, 2021 - frontiersin.org
Patients with kidney failure have notoriously weak responses to common vaccines. Thus,
immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine …
immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine …
Neutralisation sensitivity of the SARS-CoV-2 omicron BA. 2.75 sublineage
6 Sheward DJ, Kim C, Fischbach J, et al. Evasion of neutralising antibodies by omicron
sublineage BA. 2.75. Lancet Infect Dis 2022; published online Sept 1. https://doi. org/10.1016/…
sublineage BA. 2.75. Lancet Infect Dis 2022; published online Sept 1. https://doi. org/10.1016/…